Introduction
The classical roles of respiratory mucus are to maintain the hydration of the respiratory tract and to act as a protective barrier against the external environment by trapping particulate matter, including pathogens. Trapped matter can then be expelled from the airways by mucociliary clearance, the rhythmic beating of cilia bundles on the airway epithelium. It is now clear that this classical model is not complete and that mucus is a complicated, multicomponent secretion with numerous functions. The functions of respiratory mucus now include immune response regulation, the presentation of molecules that are inhibitory to pathogens, the regulation of cell differentiation and proliferation, and the maintenance of the barrier function of the epithelium.
Respiratory tract mucus is the first interaction that inhaled agents have with a potential new host. Accordingly, this mucus layer can determine the infectivity, and potentially the transmissibility, of respiratory pathogens including influenza viruses, respiratory syncytial virus (RSV) and rhinoviruses as well as pathogenic lung colonization by the opportunistic bacterial pathogen Pseudomonas aeruginosa (PA), particularly in patients with cystic fibrosis (CF). Here, we review the current understanding of respiratory tract mucus and its interactions with respiratory pathogens. We pay particular attention to studies investigating the interactions between influenza viruses and mucus and their importance in understanding influenza virus pathogenesis and host-range restriction.
Respiratory Tract Mucus
The epithelium of the respiratory tract is coated with mucus, a multicomponent secretion that has the properties of a viscous fluid or a soft, elastic solid depending on shear stress (reviewed in Lai et al., 2009 ). This secretion exists in two layers: a more viscous mucus gel layer on top of a periciliary liquid layer (PCL), where the cilia lie. The PCL is generally as deep as the cilia bundles are high, and the reduced viscosity compared to the top layer facilitates the beating of cilia bundles. While the PCL layer is less viscous than the gel layer above, diffusion of molecules into the PCL layer is impeded by membrane-spanning mucins and mucopolysaccharides associated with the cilia and the epithelium. These molecules form a type of molecular ''brush'' that helps maintain the boundary between the mucus and PCL layers. This is the ''gel-on-brush'' model of the mucus barrier (Button et al., 2012 ) ( Figure 1A ).
Mucins comprise a significant portion of airway mucus and contribute to the barrier function of mucus. Mucins are among the largest macromolecules encoded in the mammalian genome, being 200 kDa to 200 MDa in size. The majority of this weight, approximately 80%, is comprised of carbohydrate chains. Due to their size, the initial polymerization of mucins to form homodimers, which occurs after their translation, can expose mucin-producing cells to endoplasmic reticulum and Golgi stress (Martino et al., 2013) . The size of mucins after their secretion exceeds the average size of the secretory vesicles in which they are packaged. This necessitates that mucins be packaged in a condensed and dehydrated state, which is thought to be mediated by calcium-dependent crosslinking within the molecule and by charge shielding the sialic acids and sulfate groups with calcium ions (Ridley et al., 2014; Verdugo et al., 1987a Verdugo et al., , 1987b . The release of mucins from secretory granules follows a rise in pH and a fall in calcium ion concentration, which mediates mucin unfolding and rapid hydration and leads to expansion and the formation of higher-order oligomers (Ambort et al., 2012b; Ridley et al., 2014) . Mucins must adsorb in excess of 1,000 times their mass in water to achieve a viscoelasticity that facilitates mucociliary clearance (Button et al., 2012) .
Mucins share a general multidomain structure (Figures 1B and 1C) . The centers of these molecules are rich in serine and threonine residues interspersed with proline residues, termed PTS sequences. Mucins contain greater than 100 PTS sequences, which are important, as glycan chains are anchored onto the serine and threonine residues (Ambort et al., 2012a) . This region is flanked by domains with sequence homology to von Willebrand domains, similar to those found on von Willebrand factors in the blood, which facilitate clotting in the event of vascular injury. These domains are involved in polymerization via disulfide linkages between mucin molecules (reviewed in Thornton et al., 2008) .
Mucins are heavily glycosylated, such that there are 25-30 carbohydrate chains per 100 amino acids comprising 80% of the dry weight of the molecule, and this is important for their function (Brockhausen et al., 2009; Stanley et al., 2009) . Mucins contain complex glycan chains consisting mainly of O-glycans to which N-acetylgalactosamine (GalNAc) is added, followed by the additional glycan moieties galactose, N-acetylglucosamine (GlcNAc), fucose, and sialic acids (Brockhausen and Schachter, 1997) . The complexity and diversity of mucins offers a high degree of resistance to microbial proteases, as a number of diverse enzymes including proteases, glycosidases, and sialidases are needed to totally degrade the various bonds present in mucins (Corfield et al., 1992; Hoskins and Boulding, 1981) . Most mucins have a high sialic acid content which, along with the high sulfate content, results in a strongly negative surface charge, increasing the rigidity of the polymer via charge repulsion (Shogren et al., 1989) . As such, the sialic acid content of mucins is important, as it is thought to be an important determinant of the viscosity and elasticity of mucus (Puchelle et al., 1973) .
There are at least 15 mucins in the human lung ; MUC1, MUC2,  MUC3, MUC4, MUC5AC, MUC5B, MUC7, MUC13, MUC15,  MUC16, MUC18, MUC19, MUC20, MUC21 , and MUC22 (reviewed in Lillehoj et al., 2013) . The major airway mucins are MUC1, MUC4, MUC5AC, MUC5B, and MUC16. MUC1, MUC4, and MUC16 are membrane-tethered mucins, while MUC5AC and MUC5B are the major secreted mucins, secreted by goblet cells and the submucosal glands, respectively (Hovenberg et al., 1996; Wickströ m et al., 1998) . Secreted mucins are evolutionarily old, as they can be traced back to early metazoan evolution, while tethered mucins are much younger, appearing in vertebrates (Lang et al., 2007) . This history could reflect the functionality of tethered mucins being specific for vertebrates.
Experiments with knockout mice have demonstrated that Muc5b is particularly important for normal airway function, while Muc5ac is beneficial but not essential. Overexpression of Muc5ac in mice was protective against influenza virus infection, as discussed later, and Muc5ac À/À mice were viable and were capable of mucociliary clearance Roy et al., 2014) (Table 1 ). In contrast, Muc5b
mice showed a number of severe deficiencies in airway function and succumbed to bacterial infections (Roy et al., 2014) . Mucociliary clearance was severely reduced in Muc5b À/À mice, despite the presence of functional ciliated cells in the airway, such that breathing was impaired due to obstruction of the upper airways. Inflammatory infiltrates and bacteria were also present in the lower airways of Muc5b À/À mice, particularly Stapylococcus aureus, which was an important cause of mortality in Muc5b À/À mice (Roy et al., 2014) . There were also aberrations in the immune response in the lungs of Muc5b À/À mice, which were particularly evident by the accumulation of macrophages with impaired phagocytic functions. IL-23, a mediator of antimicrobial inflammatory responses, was also dramatically decreased in Muc5b À/À mice (Roy et al., 2014) (Table 1) . Therefore, there appears to be a link between mucins and the innate immune response, two important aspects of the ''first line of defense'' against pathogens. In addition to secreted mucins there are also membrane-tethered mucins that exist in the PCL, these being MUC1, MUC4, MUC16, and MUC20. Tethered mucins play a number of roles, including the activation of intracellular signal transduction pathways, regulation of the immune response, and cell differentiation and proliferation (reviewed in Lillehoj et al., 2013 ). MUC1 appears to be more strongly associated with microvilli, while MUC4 is more strongly associated with cilia (Sheehan et al., 2006) . A PA challenge model using Muc1 À/À mice revealed a role for MUC1 in regulating the inflammatory response. Postchallenge, these mice showed greater numbers of macrophages and greater amounts of the cytokines tumor necrosis factor alpha (TNFa) and keratinocyte chemoattractant (KC) in bronchoalveolar lavage fluid (BALF), both of which are markers of inflammation, which again suggests a link between mucins and the innate immune response (Lu et al., 2006; Umehara et al., 2012) . Muc1
mice were also more susceptible to greater lung injury due to inflammation following PA challenge (Lu et al., 2006; Umehara et al., 2012) . The anti-inflammatory role of MUC1 was also observed in a RSV in vitro challenge model, where a negative feedback loop was observed (Li et al., 2010) . Respiratory mucus also contains numerous other substances secreted by epithelial cells with inhibitory activity to inhaled pathogens. These substances can closely associate with mucins, suggesting that mucins act as a ''scaffold'' to present and organize these proteins. These substances include lysozyme, lactoferrin, proteases, protease inhibitors like leukoprotease inhibitor and antichymotrypsin, nitric oxide, and hydrogen peroxide (reviewed in Ganesan et al., 2013) . Lactoferrin, a bi-globular ironbinding glycoprotein that acts as an iron chelator, demonstrates antiviral and antibacterial activities and also displays other functions, including immunomodulation, modulation of cell growth, and antioxidant activity (Wakabayashi et al., 2014) . Lactoferrin also has multifaceted inhibitory actions against a number of viruses, including influenza virus (Pietrantoni et al., 2012) . Oxidants, such as nitric oxide that is produced following the induction of nitric oxide synthase-2 (NOS-2), have also been shown to inhibit viral infections. The role of nitric oxide is particularly evident in patients with CF, who are more susceptible to viral infections and show an impaired NOS-2 pathway, resulting in decreased nitric oxide in the airways (Zheng et al., 2004) . Pseudomonas aeruginosa PA is an opportunistic Gram-negative flagellated bacterial pathogen that is the primary cause of pneumonia in immunocompromised and CF patients (Gibson et al., 2003) . PA expresses several adhesins that appear to be physiologically relevant to lung colonization, such as pili on the bacterial surface that mediate epithelial cell adhesion. The bacterial flagellum is also important in this respect, as it binds the ectodomain of MUC1 (Lillehoj et al., 2002) . The sialylation of MUC1 affects PA adhesion by reducing the accessibility of b-D-galactose sites on MUC1, which are necessary for PA adhesion via flagellin Pastoriza Gallego and Hulen, 2006) . Sialyl-Lewis x moieties on mucins in particular appear to be preferential binding sites for PA via flagellin (Colomb et al., 2014; Scharfman et al., 1999) . Sialyl-Lewis X moieties are tetrasaccharide-terminating glycan chains on N-and O-linked glycans that are important blood type antigens. They are located on mucins and the surface of leukocytes, where they are involved in immune cell recruitment. There is evidence that PA can increase the Sialyl-Lewis X content on mucins via pyocyanin, a redox-active tricyclic toxin secreted by PA, thereby making the host environment more favorable for attachment and colonization (Jeffries et al., 2015) . Pyocyanin has also been shown to stimulate the release of pro-inflammatory cytokines and MUC5AC and MUC2, which was mediated by the epidermal growth factor receptor (EGFR) pathway (Rada et al., 2011) . PA is the most important bacterial infection associated with CF, a genetic disorder caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR), a chloride channel protein. CF is characterized by mucus hypersecretion that leads to airway blockages and chronic bacterial lung infections predominated by PA that result in inflammation and progressive pulmonary damage (Hartl et al., 2012) . There are indications that the lung environment in CF is proinflammatory, a state further exacerbated by the chronic bacterial infections common in CF (Berger, 2002) . Inflammation exacerbates these infections as proinflammatory cytokines such as TNFa, IL-6, and IL-8 increase Sialyl-Lewis x expression on mucins, which facilitates PA attachment (Colomb et al., 2014; GrouxDegroote et al., 2008) (Figures 2A and 2B ). Mucins obtained from CF airways are enriched with Sialyl-Lewis x , and this has been shown to correlate to the severity of infection in CF (Davril et al., 1999) . In the CF lung, PA is very difficult to eradicate, despite host immune responses and adequate concentrations of antibiotics in the airways during treatment. This is thought to result from PA forming a biofilm within the thick mucus of the CF lung. In this setting, PA adapts by losing motility, forming aggregates and relying on anaerobic respiration, which contributes to resistance against multiple front-tier antibiotics (Staudinger et al., 2014) ( Figure 2C ). PA strains isolated from CF patients with chronic infections are often nonmotile, lacking flagellin and pilin, while environmental isolates and isolates obtained during early colonization are motile (Luzar et al., 1985) . These nonmotile strains are also resistant to phagocytosis by macrophages (Lovewell et al., 2014; Luzar et al., 1985) . In contrast, non-CF mucus has been shown in vitro to inhibit adhesion and the subsequent loss of motility (Yeung et al., 2012) . PA has also been shown to impact mucin secretion via lipopolysaccharide (LPS), a component of the bacterial cell wall. LPS can upregulate MUC2 and MUC5AC gene expression, contributing to the excessive mucus production and airway blockage seen in CF. PA LPS upregulates MUC2 expression via a c-Src-Ras-MEK1/MAPK signaling pathway, leading to the activation of nuclear factor (NF)-kB, which in turn triggers MUC2 gene transcription (Li et al., 1997) . PA LPS has also been shown to generate reactive oxygen species (ROS) via the PKC-NADPH oxidase signaling pathway in epithelial cells, which leads to upregulation of MUC5AC transcription (Li et al., 2013; Yan et al., 2008) . The induction of CFTR-dependent airway surface liquid secretion following exposure to bacteria has also been observed in swine tracheal explants (Luan et al., 2014) . It is hypothesized that PA may be responsible, via these modes of actions described, for the excessive mucus production seen in CF patients, rather than the CF lung environment itself.
Respiratory Syncytial Virus RSV is the most common cause of bronchiolitis and viral pneumonia, such that by the age of three, all children will have been infected by RSV at least once (reviewed in Pickles and DeVincenzo, 2015) . The epithelium of the upper respiratory tract is the major target for RSV during the early stages of infection. Later stages of infection are characterized by inflammation and obstruction of the airways due to the formation of mucus plugs containing mucus, fibrin, cellular debris, and lymphocytes (Aherne et al., 1970) . RSV is an enveloped virus of the family Paramyxoviridae that contains a single-stranded, nonsegmented, negative-sense RNA genome. Among the 11 separate proteins encoded by RSV, three are transmembrane surface glycoproteins labeled glycoprotein (G), fusion (F), and small hydrophobic (SH). The function of SH is largely unknown (reviewed in Collins and Crowe, 2013).
The major attachment protein of RSV is the G protein, and most of the ectodomain of the G protein has a mucin-like structure, with a high content of PTS sequences and abundant glycosylation. The F protein facilitates viral fusion with host cell membranes to initiate infection, including cell-to-cell fusion leading to syncytia formation. Being major neutralizing antigens, both the F and G proteins can influence the immune response and mucus production in the lung (Connors et al., 1991) .
The F protein has also been linked to RSV pathogenicity in the lower respiratory tract. Increased F-mediated RSV fusogenicity has been correlated to increased viral load early during infection in mice, resulting in severe lung damage (Hotard et al., 2015) . This was linked to increased neutrophil infiltration of the lung, increased amounts of TNF-a, a neutrophil recruitment factor that stimulates the production of MUC5AC and MUC1, and increased numbers of IL-13-producing CD4 + T cells in the lung (Stokes et al., 2013) . Neutrophil numbers correlated to mucus production in the lung and associated with the formation of mucus plugs, mediated by TNF-a, in more severe cases (Bataki et al., 2005; Lora et al., 2005) . The RSV G protein has also been associated with disease severity and mucus secretion in mouse models of RSV infection, independent of its role in viral replication (Boyoglu-Barnum et al., 2013) . This may be mediated by type 2 cytokine expression, particularly IL-13, IL-4, and IL-5 and the chemokine MCP-1, as type 2 cytokines can induce mucin secretion (Temann et al., 1997; Zuhdi Alimam et al., 2000) .
Signaling via the chemokine receptor CXCR2 has also been shown to contribute to increased mucus production via increased Muc5ac expression in a mouse model of RSV infection following allergic sensitization (Miller et al., 2003) . Increased mucus production was thought to be due to increased IL-17 in the lung, a proinflammatory cytokine secreted by activated T cells (Chen et al., 2003; Hashimoto et al., 2004) . The importance of IL-17 was shown in vivo using a knockout mouse model (Hashimoto et al., 2005) . The PA toxin pyocyanin (red dots) stimulates mucus hypersecretion by goblet cells (dashed arrow) and induces the production and release of the proinflammatory cytokines tumor necrosis factor alpha (TNFa) and interleukins 6 (IL-6) and 8 (IL-8) (solid arrow). (B) TNFa, IL-6, and IL-8 lead to inflammation and upregulate the sialyl-Lewis x biosynthesis glycosyltransferases core 2/core 4 beta-1,6-Nacetylglucosaminyltransferase (C2/4GnT) and a2,3-sialyltransferase IV (ST3Gal-IV) via the phosphoinositol-specific phospholipase C (PI-PLC) pathway (gray arrow), leading to an increase in sialyl-Lewis x content and increased PA binding. (C) PA is commonly found in a biofilm in the CF lung. In this setting, PA aggregate, lose their motility, and switch to anaerobic respiration, facilitating resistance to cells of the immune system and to multiple front-tier antibiotics. Recently it has been shown that RSV and human metapneumovirus (hMPV), two RNA viruses of the Paramyxoviridae family, induce significantly different mucin expressions in A549 cells, an epithelial cell line (Bañ os-Lara Mdel et al., 2015) . Although these two viruses are similar in structure and pathogenicity, it is interesting to see the differential expression of MUC2, MUC5AC, and MUC5B as well as membrane-bound mucins. RSV infection can change the composition of infected airway epithelium by increasing MUC5AC-secreting cells, indicating the important role of mucus secretion in pathogenicity (Persson et al., 2014) .
Influenza Viruses
Influenza viruses are important respiratory pathogens that place a significant burden on society, such that influenza ranks in the top ten causes of death in the United States (Hoyert and Xu, 2012) . Seasonal influenza viruses are responsible for a significant amount of mortality and morbidity during the influenza season, and influenza pandemics, which occur sporadically, can be associated with much greater disease severity and higher mortality rates. The Influenza Virus Replication Cycle and the Roles of Hemagglutinin and Neuraminidase Influenza viruses are enveloped and contain protein spikes protruding from the viral membrane consisting of the hemagglutinin (HA) and neuraminidase (NA) proteins, which play critical roles in the viral life cycle. HA exists as a trimer on the surface of influenza viruses and mediates cell attachment and viral entry. HA binds to cells via N-acetylneuraminic acids (sialic acids) located on the distal ends of oligosaccharide chains on the cell surface (reviewed in Palese and Shaw, 2013) . The dense, diverse coating of glycoconjugates, glycoproteins, proteoglycans, glycolipids, and polysaccharides, such as hyaluronic acid, on the surface of cells is termed the glycocalyx. The glycocalyx has numerous functions, including structural roles in proteins, protein folding, and mediation of self-recognition by the immune system (reviewed in Springer and Gagneux, 2013) . The structure of these chains and the linkages they form with the terminal sialic acid resides are important determinants of influenza virus host range, which is further described below. Following sialic acid-HA binding, the virus is internalized into the cell by endocytosis or macropinocytosis and trafficked to the endosome, where a pH-dependent conformational change in HA results in the release of the viral ribonucleoproteins and subsequent viral replication (reviewed in Palese and Shaw, 2013) .
Following replication and assembly, progeny viruses are attached to the surface of the infected cell via the HA-sialic acid interaction. At this point, NA cleaves the sialic acid residues bound to the HA, releasing the progeny viruses. Therefore, the interaction of influenza viruses with the glycocalyx is very important in the viral life cycle. However, respiratory mucus also contains sialic acids and glycoproteins, and the influenza virus interaction with these is also important. The Interactions between Influenza Virus and Respiratory Mucus and the Importance of Neuraminidase Influenza viruses are currently classified in the Orthomyxoviridae family but were initially classified as myxo viruses, from the Greek myxa (mucus), based on their reactivity for certain mucins (Andrewes, 1954) . The interaction between influenza viruses and mucins was first identified in studies conducted in the 1940s and 1950s (Anderson et al., 1948; Burnet, 1951) . The observation that receptor-destroying enzyme from Vibrio cholerae could reduce the inhibitory action of mucoproteins over time in a similar fashion to influenza viruses was suggestive of an influenza virus sialidase (Stone, 1949) . This sialidase was presented by Gottschalk, in which the authors ''propose the name 'neuraminidase' for the enzyme and define its action as the hydrolytic cleavage of the glycosidic bond joining the keto group of neuraminic acid to D-galactose or D-galactosamine and possibly to other sugars'' (Gottschalk, 1957) .
Since these studies, NA has been shown to also be important in determining whether viruses can penetrate the mucus barrier to infect underlying cells. The NA inhibitor oseltamivir was shown to inhibit the infection of mucus-producing normal human bronchial epithelial (NHBE) cells (Matrosovich et al., 2004) , and additional studies achieved similar results using A549 cells and Madin-Darby canine kidney (MDCK) cells (Ohuchi et al., 2006) (Figure 3A ). However, when oseltamivir was added to erythrocytes, which express sialic acids on their surface, influenza virions became embedded in the erythrocyte membrane, while viruses remained attached to the cell surface in the absence of oseltamivir, indicating that NA plays a role in virus entry (Ohuchi et al., 2006) .
It was hypothesized that NA may facilitate infection by cleaving sialic acids on mucins to prevent viruses from becoming trapped before they infect the epithelium. This was investigated in vitro by adding influenza viruses to a layer of porcine respiratory mucus. Over time, viruses penetrated the mucus layer and the extent of penetration could be facilitated or impaired by the addition of exogenous NA or oseltamivir, respectively, indicating the importance of NA in mucus penetration (Yang et al., 2014) . This is likely achieved via cleavage of sialic acids, thus preventing or reversing viral attachment to mucus. Consistent with this hypothesis, sialidase pretreatment of human trachea and bronchial tissues containing a mucus layer reduced viral binding to mucus (Burnet, 1947; Cohen et al., 2013) . Influenza virus has also been shown to be inhibited by exosomes, which are secreted cellular microvesicles present in mucus (Kesimer et al., 2009) . Exosomes are rich in a2,6 sialic acids and interact with MUC1, MUC4, and MUC16. Cultures of human tracheobronchial epithelial cells secrete exosomes, and these are inhibitory to influenza virus infection of MDCK cells in vitro, via virus binding to sialic acids on the exosome (Kesimer et al., 2009) . Mucins have been shown to be protective against influenza virus as mice overexpressing Muc5ac (Muc5ac-Tg) exhibited 9.3-fold less viral replication in the lung compared to wild-type . While Muc5ac expression was approximately 20-fold greater in the large and small airways in Muc5ac-tg mice compared to wild-type, there was no evidence of airway obstruction or lung inflammation. Further, BALF from Muc5ac-Tg mice showed greater inhibition of viral infection of MDCK cells compared to wild-type BALF (Table 1) .
Respiratory mucus may be a species barrier for influenza viruses. Experiments in vitro demonstrated that an overlay of human mucus can inhibit the infection of underlying MDCK cells by both swine-and human-origin viruses in vitro, while swine mucus does not appear to inhibit infection (Cohen et al., 2013; Zanin et al., 2015) (Figures 3A and 3B) . The interaction between influenza viruses and mucus may also be a factor in viral transmissibility, particularly in the context of NA enzymatic activity. Pandemic H1N1 viruses isolated in swine with almost undetectable NA enzymatic activity were significantly inhibited by mucus in NHBE cell cultures in vitro (Zanin et al., 2015) . These viruses did not transmit via aerosols in ferrets, and direct contact transmission was severely attenuated (Zanin et al., 2015) . Similarly, viruses expressing NA proteins with short stalks that have decreased enzymatic activity against multivalent substrates such as those found on cells are inhibited by mucus in vitro (Castrucci and Kawaoka, 1993; Matsuoka et al., 2009) . Replacing the NA of an efficiently transmitted H5N1 virus with an avian shortstalk NA protein abrogated aerosol transmission of the virus and reduced the efficiency of direct contact transmission in ferrets (Blumenkrantz et al., 2013) . These studies strongly suggest a link between mammalian transmission and the interaction between mucus and NA ( Figure 3C ).
Sialic Acids and Host Restriction of Influenza Viruses
While host restriction of influenza viruses is a multifactorial phenomenon that is not fully understood, the HA binding preference for different sialic acids is involved. The types of sialic acids expressed are species dependent, but N-acetylneuraminic acid (Neu5Ac) and N-glycolylneuraminic acid (Neu5Gc) are common. Neu5Gc is converted from cytidine monophosphate-N-acetylneuraminic acid by the enzyme cytidine monophosphate-N-acetylneuraminic acid hydroxylase (Irie et al., 1998) . Neu5Gc is absent in humans and sauropsids (birds and reptiles), as this enzyme is mutated and nonfunctional, although pigs and mice produce this enzyme and thus express Neu5Gc (Chou et al., 1998; Scharfman et al., 1999; Schauer et al., 2009) . Old World monkeys also express Neu5Gc, while New World monkeys and humans do not. This gene was lost approximately 3 million and 30 million years ago, respectively, in ancestral hominids and New World monkeys (Springer et al., 2014) .
Ferrets, like humans, also lack a functioning cytidine monophosphate-N-acetylneuraminic acid hydroxylase and therefore also do not express Neu5Gc (Ng et al., 2014) . This is significant, as ferrets are widely used to study influenza virus infection and transmission, as the expression and distribution of sialic acids in the ferret respiratory tract is similar to humans, although not identical (Jia et al., 2014; van Riel et al., 2006) . Neu5Gc may act as a decoy receptor for influenza viruses rather than a functional receptor, as shown using a Neu5Gc-expressing human lung cell line. The infectivity of a virus that binds to Neu5Gc was decreased in cells expressing Neu5Gc compared to cells only expressing Neu5Ac, and Neu5Gc-binding viruses accumulated on the surface of cells expressing Neu5Gc (Takahashi et al., 2014) . In contrast, the infectivity of a virus that cannot bind to Neu5Gc was similar in cells either expressing or not expressing Neu5Gc (Takahashi et al., 2014) .
There are also species differences in the types of linkages that exist between sialic acid, at the extremity of the glycan chain, and the underlying galactose molecule. The upper respiratory tract of humans primarily contains sialic acids bound to galactose by an a2,6 linkage, although a2,3 linkages are also present, while in the bronchus and alveoli, a2,3 linkages predominate (Gagneux et al., 2003; Nicholls et al., 2007; Shinya et al., 2006) . The significance of these linkages with respect to influenza virus host restriction has been extensively studied. These studies showed that influenza viruses of avian and equine origin tend to bind better to sialic acids with a2,3 linkages, while human influenza viruses bind better to sialic acids with a2,6 linkages (Suzuki et al., 2000) . The sialic acid binding preferences of avian and mammalian viruses correlates somewhat to the sialic acid distribution in human and avian hosts. In avian hosts, a2,3-linked sialic acids predominate in the gastrointestinal tract, while a2,6-linked sialic acids are more abundant in the upper respiratory tract of humans (Gambaryan et al., 2002; Nicholls et al., 2007; Shinya et al., 2006) . The porcine respiratory tract has been shown to express both a2,3 and a2,6-linked sialic acids, and for this reason swine have been referred to as ''mixing vessels'' that foster reassortment of influenza viruses (Ito et al., 1998) . The relative lack of a2,3-linked sialic acids in the upper respiratory tract of humans is thought to be a host barrier to avian influenza viruses. This is evident in the strains of influenza viruses that have caused pandemics. These viruses contain HA proteins originating from nonhuman species yet exhibit specificity for human-type receptors (Childs et al., 2009; Matrosovich et al., 2000; Stevens et al., 2006) . Further, viruses that preferentially bind to a2,3-linked sialic acids are not transmitted via the airborne route in mammals, while viruses with mixed binding preferences have an intermediate transmission phenotype (Matrosovich et al., 2000; Tumpey et al., 2007) . The relatively low expression of a2,3-linked sialic acids in the mammalian upper respiratory tract is likely a major contributor to this restriction.
While the sialic acid linkages are important for host range specificity of influenza viruses, this is an oversimplification. There are numerous different species of a2,3-and a2,6-linked sialic acids present in the glycocalyx with varying length, topology, and complexity. The location of these sialic acids in the glycocalyx may also come to bear. For example, sialic acids located on glycoproteins such as mucins may show differential importance compared to those on gangliosides, which are glycolipids with sialic acid content. This is owing to their locations in the glycocalyx, as gangliosides generally lie close to epithelium and underneath larger glycoproteins that can display many glycan chains farther away from the epithelial layer. To attest to this complexity, the topology of sialic acids has been shown to impact virus host range. Human-adapted HA proteins have been shown to bind preferentially to a2,6-linked sialic acids on long glycan branches, which can assume an ''umbrella-like'' topology, while avianadapted HAs do not bind to these structures. In the case of H5N1 viruses, those viruses that were efficiently transmitted in the ferret model showed binding preferences to long a2,6-linked sialic acids, while those that did not transmit efficiently bound preferentially to a2,3-linked or short a2,6-linked sialic acids, both of which assume a ''cone-like'' topology (Chandrasekaran et al., 2008; Stevens et al., 2006) .
There is some experimental evidence that glycan structures play a role in influenza virus infection, although more work is needed to fully elucidate their importance. Experiments in cells lacking complex N-linked glycosylation showed influenza virus attachment, but not endocytosis. This indicates that sialic acids alone are not sufficient for infection and that N-linked glycoproteins are required for viral entry (Chu and Whittaker, 2004) . However, other cell lines lacking complex N-linked glycosylation were highly susceptible to influenza virus infection, although serum interfered with infectivity, indicating that sialylated N-glycans are required for viral entry in the presence of serum (de Vries et al., 2012) . This apparent importance of N-linked glycans may indicate that influenza viruses can evolve away from inhibition by mucus, which is mostly O-glycosylated.
NA displays preferences for both sialic acid types and linkages, which was studied in human N2 viruses isolated from 1957 to 1987. These N2s originally showed enzymatic activity only against a2,3-linked sialic acids; however, activity against a2,6-linked sialic acids became apparent over time, suggesting a selective advantage was obtained (Kobasa et al., 1999) . N2 NAs of avian, swine, and human viruses all showed high specificity for NeuAc; however, there were differences in NeuGc specificity, as avian viruses showed low to moderate specificity for NeuGc, while swine viruses showed high specificity for NeuGc linkages (Kobasa et al., 1999) . The specificity of N2s from the human viruses tested for NeuGc linkages appeared to change from low to moderate specificity between 1957 and 1962 to high in 1968, then returning to low to moderate by 1972, for reasons which are not fully understood (Kobasa et al., 1999) . Some NA proteins, such as those from H3N2 viruses, can also bind to sialic acids and NAs from avian viruses also contain a hemadsorbing site away from the enzymatic active site (Laver et al., 1984; Lin et al., 2010; Zhu et al., 2012) . The biological significance of these binding attributes of NA is not clear.
Perspective
The current understanding of respiratory mucus has revealed a complexity and functionality far beyond the classical role ascribed to it. Much of this knowledge has come from studying mucins, the large, heavily glycosylated, multidomain proteins that give mucus many of its physical properties. The interaction between mucins and respiratory pathogens is also more complicated than mere entrapment. Mucins have been revealed to play an integrated role in the host response to pathogens, both before and during the immune response, and the absence or disturbance of this role can be highly detrimental to the host. Despite the importance of mucins, current understanding of their functions is limited, which is partly due to the complexity of mucus and its interactions.
Mucus appears to be an important host barrier to influenza viruses. The NA protein of influenza has been shown to be important in evading this barrier, such that viruses with low NA activity, or viruses treated with NA inhibitors, are severely impeded by mucus in vitro. Interestingly, these viruses can still infect animals and be transmitted; however, this transmission is severely attenuated, pointing to a role of respiratory mucus in viral transmission, which is not understood. Also not understood is the potential role of mucus as a host-restriction factor for influenza viruses. In vitro data suggest that respiratory mucus could be a host restriction factor between swine and human hosts, but is this also true in vivo, and is it also true between other hosts of influenza viruses? If so, is this restriction merely due to the sialic acid content of mucus, or are there other components involved? Could mucus be an important selective pressure for transmissible viruses? Answering these questions is made more difficult by the complexity of mucus and the incomplete characterization of it. Therefore, further understanding of both mucus and the mucus-influenza virus interaction is likely to continue to provide insights into influenza virus transmission, host restriction, and viral adaptation to new hosts that could be invaluable in understating the genesis of new strains of influenza virus.
